The US Type 1 Diabetes Therapeutics Market represents a major share of the global industry, supported by a high prevalence of type 1 diabetes, advanced healthcare infrastructure, and strong adoption of innovative diabetes management technologies. Healthcare providers across the United States are increasingly utilizing advanced insulin formulations, insulin pumps, continuous glucose monitoring...